These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5203744)

  • 1. [Current therapy of hemoblastosis].
    Bibus L
    Dtsch Schwesternztg; 1970 Dec; 23(12):624-9. PubMed ID: 5203744
    [No Abstract]   [Full Text] [Related]  

  • 2. [The present & future in the therapy of hemoblastosis].
    DI GUGLIELMO G
    Riforma Med; 1957 Dec; 71(49):1381-3. PubMed ID: 13528572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic drugs in therapy of hemoblastosis].
    TEODORI S
    Athena; 1957 Feb; 23(2):54-63. PubMed ID: 13412606
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of recombinant interleukin-2 in therapy for hematologic malignancies.
    Dutcher JP; Wiernik PH
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):33-40. PubMed ID: 8284690
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the current status and outlook for treatment of hemoblastoses and similar diseases. (Statistics, experience, reality and speculation)].
    Jedlicka V
    Vnitr Lek; 1967 Nov; 13(11):1096-106. PubMed ID: 4866496
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood component therapy in hematological diseases].
    Abdulkadyrov KM
    Klin Med (Mosk); 1994; 72(2):10-3. PubMed ID: 8015232
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytostatic treatment of haemoblastoses and associated conditions.
    NETOUSEK M
    Cesk Onkol; 1956; 3(3):240-50. PubMed ID: 13396823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gene therapy of blood disorders].
    Jedrzejczak WW
    Acta Haematol Pol; 1995; 26(2 Suppl 1):25-33. PubMed ID: 7653232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urological and nephrological complications in diseases of the blood system].
    Epifanov NS; Papikian AI
    Urol Nefrol (Mosk); 1993; (4):49-52. PubMed ID: 8310571
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hemoblastosis].
    MELLI G; GRIFONI V
    Minerva Med; 1960 Oct; 51():3467-74. PubMed ID: 13769234
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone marrow transplantation in malignant proliferative hematologic diseases].
    Adamczyk MB; Rupniewska ZM
    Pol Tyg Lek; 1984 Feb; 39(7):229-32. PubMed ID: 6379621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hematopoietic stem cell transplantation in pediatric onco-hematology].
    Tamaro P; Barth E
    Recenti Prog Med; 2001 Apr; 92(4):278-82. PubMed ID: 11388047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzyme therapy of hemoblastosis with L-asparaginase].
    Pietschmann H; Kolarz G
    Wien Z Inn Med; 1969; 50(4):148-56. PubMed ID: 5262208
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical results with phosphoramide treatment of hemoblastosis].
    CERNY V; SANDOR L; UJHAZY V; WINKLER A
    Cesk Onkol; 1956; 3(1):87-9. PubMed ID: 13374816
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC.
    Beatty PG
    Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current possibilities and prospects in hematologic diseases].
    Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):481-6. PubMed ID: 6113667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of blood diseases in a specialized department].
    Beran M; Carlmark B; Ehn L; Ericsson F; Forsberg K; Hast R; Höglund S; Lantz B; Pihlstedt P; Reizenstein P; Skårberg KO; Udén AM; Osby E
    Lakartidningen; 1980 Apr; 77(17):1635-9. PubMed ID: 6770206
    [No Abstract]   [Full Text] [Related]  

  • 18. What's new in haematology?
    Hounsell J; Isbister JP
    Med J Aust; 1994 Jan; 160(1):38-40. PubMed ID: 8271984
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell surface antigen and molecular targeting in the treatment of hematologic malignancies.
    Countouriotis A; Moore TB; Sakamoto KM
    Stem Cells; 2002; 20(3):215-29. PubMed ID: 12004080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive care therapy for patients with hematological diseases.
    Anger B; Schmeiser T; Sigel H; Heimpel H
    Haematol Blood Transfus; 1987; 30():519-23. PubMed ID: 3623244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.